Insights on how real-world data from registries can be used as external control arms in clinical trials.
While clinical registries are a valued source of longitudinal, real-world data, registries also provide expanded options for research and advancing randomized clinical trials. Understanding when and how to use registries in these use cases is quite nuanced and mandates a targeted approach and innovative expertise.
In this video, Heather Litman, CorEvitas Vice President, Biostatistics, provides interviewer Jeanne Linke Northrup with a deep dive into the expanded use of registries as external control arms in clinical trials.
Watch this video and learn more:
- Challenges in rare condition trials for biopharma companies.
- Purpose of control population in traditional clinical trials.
- Enhancing control groups with hybrid control arms.
- Prospective registries as real-world controls.
- Minimizing bias in RCT control groups vs. real-world/hybrid controls.
